Latest Regulatory News

CDL Investments New Zealand (NZX: CDI) has secured Fast-track referral approval for its Middle Road residential development in Havelock North, paving the way for up to 350 new homes and reinforcing its Hawke’s Bay growth pipeline.

Australian Strategic Materials (ASM) has postponed its shareholder Scheme Meetings to early August 2026, following Energy Fuels’ major financing and acquisition moves. The updated timetable awaits court and regulatory approvals, with the ASM board maintaining its unanimous recommendation.

ALS Limited (ASX:ALQ) has delivered a landmark FY26 with underlying net profit after tax surging 25.8% to $381.2 million, beating 2027 targets a year early and raising its dividend by 10%. The company continues to invest heavily in automation, digital initiatives, and laboratory expansions while advancing its climate strategy amid a post-year-end cyber incident.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

Krakatoa Resources has kicked off its 2026 drilling campaign at the Zopkhito Project in Georgia, aiming to convert a significant foreign resource estimate into a JORC-compliant Mineral Resource Estimate while advancing early mine development studies.

Ampol launches a A$400 million delayed-draw subordinated notes facility to refinance upcoming debt maturities, locking in long-dated funding with flexible drawdown options.

SIV Capital has been advised by the ASX of a significant risk that it will fail to meet key listing requirements, prompting the company to explore alternative paths forward.

Novatti has cashed in $1.2 million by selling part of its AUDC shares at $0.80 each, marking its first divestment since incubating the stablecoin issuer in 2022, yet keeps a substantial holding to benefit from future growth.

HMC Capital has cleared key regulatory hurdles and locked in a $603 million investment from KKR, trimming its stake in the energy platform now rebranded as Illuma Energy. The deal paves the way for expanded battery storage projects and underpins a targeted development milestone in 2026.

CZR Resources (ASX:CZR) has launched a recommended all-scrip takeover bid for Zuleika Gold (ASX:ZAG), valuing the company at $44.8 million and offering a significant premium to Zuleika shareholders.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.

2 Cheap Cars Group maintained steady revenue and profit in FY26 despite softer vehicle sales and regulatory headwinds, driven by strong EV demand and record finance and insurance penetration.